Randomized, placebo-controlled, single-dose, crossover study to evaluate the safety, pharmacokinetics, and pharmacodynamics of BMS-686117 in subjects with type 2 diabetes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs BMS 686117; Exenatide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 16 Mar 2009 Biomarkers information updated
- 01 Nov 2007 Status changed from in progress to completed.
- 12 Sep 2007 Status change